Full Text View
Tabular View
Study Results
Related Studies
SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
This study has been completed.
Study NCT00522951   Information provided by Bayer

First Received on August 29, 2007.   Last Updated on October 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial